Stay updated with breaking news from Peter Marks. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The FDA has approved lifileucel suspension (Amtagvi) for adult patients with unresectable or metastatic melanoma following prior treatment with a PD-1 inhibitor, and if BRAF V600 mutation positive, a BRAF inhibitor, with or without a MEK inhibitor.
Amtagvi is intended to help patients with melanoma that cannot be removed with surgery or has spread to other parts of the body.
I’m 21. I no longer like clubbing and neither do my friends. Generation Z are bidding farewell to the clubbing scene and it’s causing nightclubs to close across the country.
The Food and Drug Administration (FDA) announced Friday that it approved a ground breaking cellular therapy treatment for patients with advanced melanoma, and surgery has been unsuccessful. Amtagvi, a type of T-cell therapy, involves boosting immune cells within tumor tissue to help the body fight off the cancer. During the treatment, the patient’s t-cells are…
Amtagvi is intended to help patients with melanoma that cannot be removed with surgery or has spread to other parts of the body.